Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors

Clinical trial NCT00743379 · COMPLETED

Trial details

NCT number: NCT00743379
Sponsor: Threshold Pharmaceuticals
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer Prostate Cancer Pancreatic Cancer

Start date: 2008-08-01
Primary completion: 2013-07-01
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.